Full Press Release Details
LIFEVANTAGE ANNOUNCES PRELIMINARY UNAUDITED SECOND QUARTER 2011 RESULTS
Company Anticipates Record Operating Profit on Highest Quarterly Net Revenue to Date
Diego, CA, January 19, 2011, LifeVantage Corporation (OTCBB: LFVN), the
maker of science-based solutions to oxidative stress, announced preliminary unaudited net revenue
for its second fiscal quarter of 2011. The Company anticipates net revenue of approximately $7.4
million for the three month period ended December 31, 2010. This represents an increase of
approximately $1.0 million or 15% over net revenue of $6.4 million for the three month period ended
September 30, 2010. This is also an approximate $4.9 million or 196% increase in net revenue over
the $2.5 million net revenue reported for the same quarter last year.
Along with recording net revenue of approximately $7.4 million, the Company also anticipates
reporting operating income of at least $500,000 in the second fiscal quarter 2011. Operating
income of $500,000 would generate nearly a 7% operating profit margin for the quarter, compared to
an operating loss of $2.7 million or 109% in the same quarter last year.
We are pleased to announce that we are exceeding our second quarter guidance and we
anticipate reporting our highest quarterly net revenue and operating profit to date, stated David
W. Brown, President Chief Executive Officer of LifeVantage. Carrie McQueen, Chief Financial
Officer commented, After giving second quarter guidance for a 10% improvement in net revenue, we
are very pleased to be exceeding our estimates. Additionally, we have achieved growth while
maintaining conservative spending in operations. We are proud to report our 8th
consecutive quarter of net revenue growth, our 6th consecutive quarter of improvement in
operating income or loss, and our 2nd consecutive quarter of operating income. We remain
focused on achieving sequential growth in future quarters.
About LifeVantage Corporation
LifeVantage Corporation is a publicly traded (OTCBB: LFVN), science-based, nutraceutical company
dedicated to helping people reach their health and wellness goals while creating business
opportunities. Founded in 2003 and based in San Diego, CA, LifeVantage currently offers two
anti-aging and wellness products: Protandim , a dietary supplement that combats oxidative stress,
and LifeVantage TrueScience Anti-Aging Cream, a scientifically-based skin care product. For more
information, visit www.LifeVantage.com.
Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified
by words such as believes, anticipates, intends, plans, seeks and similar references to
the future. Examples of forward-looking statements include, but are not limited to, statements we
make regarding our anticipated results of operations and future growth. Such forward-looking
statements are not guarantees of performance and the Company s actual results could differ
materially from those contained in such statements. These forward-looking statements are based on
the Company s current expectations and beliefs concerning future events affecting the Company and
involve known and unknown risks and uncertainties that may cause the Company s actual results or
outcomes to be materially different from those anticipated and discussed herein. These risks and
uncertainties include, among others, the risk factors contained in the Company s Annual Report on
Form 10-K and its Quarterly Report on Form 10-Q under the caption Risk Factors , and in other
documents filed by the Company from time to time with the Securities and Exchange Commission. The
Company cautions investors not to place undue reliance on the forward-looking statements contained
in this document. All forward-looking statements are based on information available to the Company
on the date hereof, and the Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after the date of this document,
except as required by law.
Investor Relations Contact:
(858) 312-8000 Ext. 4